# Therapeutic Areas Page - Visual Guide

## Overview

This visual guide shows the layout and design of the Therapeutic Areas Spider Web Visualization page.

## Desktop Layout (1920x1080)

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                    AURORA GRADIENT BACKGROUND                                    â”‚
â”‚                           (Pulsing cyan + purple radial gradients)                              â”‚
â”‚                                                                                                  â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚
â”‚  â”‚ ğŸ”· [THERAPEUTIC AREA INTELLIGENCE]                  [â†» REFRESH DATA] â± 14:32:15         â”‚  â”‚
â”‚  â”‚    Spider Web Analysis: Science Attributes Ã— Market Dynamics                             â”‚  â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚
â”‚                                                                                                  â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”   â”‚
â”‚  â”‚  THERAPEUTIC AREAS       â”‚  SPIDER WEB ANALYSIS                                         â”‚   â”‚
â”‚  â”‚  5 AREAS                 â”‚  Science Attributes (0-10 Scale)                             â”‚   â”‚
â”‚  â”‚                          â”‚                                                              â”‚   â”‚
â”‚  â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚                     Unmet Need                               â”‚   â”‚
â”‚  â”‚  â”‚ Duchenne MD        â”‚  â”‚                          â—¢                                   â”‚   â”‚
â”‚  â”‚  â”‚ â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€  â”‚  â”‚               Regulatoryâ”ƒ                                   â”‚   â”‚
â”‚  â”‚  â”‚ Ultra-rare X-linked â”‚  â”‚            Support      â”ƒ      â”ƒ Market Size                â”‚   â”‚
â”‚  â”‚  â”‚ disorder with high  â”‚  â”‚                    â•±â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â•²                     â”‚   â”‚
â”‚  â”‚  â”‚ mortality...        â”‚  â”‚                 â•±â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â•²                   â”‚   â”‚
â”‚  â”‚  â”‚ â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€ â”‚  â”‚              â•±â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â•²                â”‚   â”‚
â”‚  â”‚  â”‚ PREVALENCE          â”‚  â”‚            â•±â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â•²              â”‚   â”‚
â”‚  â”‚  â”‚ 1 in 3,500-5,000    â”‚  â”‚          â•±â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â•²             â”‚   â”‚
â”‚  â”‚  â”‚ PEAK SALES          â”‚  â”‚    Scientificâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€Competitive      â”‚   â”‚
â”‚  â”‚  â”‚ 5-8B globally       â”‚  â”‚    Validation         â”ƒ        â”ƒ         Intensity         â”‚   â”‚
â”‚  â”‚  â”‚ â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€ â”‚  â”‚          â•²â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â•±             â”‚   â”‚
â”‚  â”‚  â”‚ COMPANIES:          â”‚  â”‚           â•²â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â•±              â”‚   â”‚
â”‚  â”‚  â”‚ SRPT, BMRN, ARWR... â”‚  â”‚             â•²â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â•±                â”‚   â”‚
â”‚  â”‚  â”‚ â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€ â”‚  â”‚               â•²â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â•±                  â”‚   â”‚
â”‚  â”‚  â”‚ [Exon skipping]     â”‚  â”‚                  â•²â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â•±                     â”‚   â”‚
â”‚  â”‚  â”‚ [Gene therapy]      â”‚  â”‚                     â•²â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”¼â•±                        â”‚   â”‚
â”‚  â”‚  â”‚ [Myosin inhibition] â”‚  â”‚         Reimbursementâ”ƒ        â”ƒPatient Advocacy           â”‚   â”‚
â”‚  â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚                      Potential                              â”‚   â”‚
â”‚  â”‚                          â”‚                                                              â”‚   â”‚
â”‚  â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚  â•”â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•—     â”‚   â”‚
â”‚  â”‚  â”‚ Cardiovascular     â”‚  â”‚  â•‘ LEGEND                                             â•‘     â”‚   â”‚
â”‚  â”‚  â”‚ â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€  â”‚  â”‚  â•‘ â–¬â–¬â–¬ DMD (Cyan)                                    â•‘     â”‚   â”‚
â”‚  â”‚  â”‚ Large market with   â”‚  â”‚  â•‘ â–¬â–¬â–¬ Cardiology (Amber)                            â•‘     â”‚   â”‚
â”‚  â”‚  â”‚ significant unmet   â”‚  â”‚  â•‘ â–¬â–¬â–¬ IBD (Green)                                   â•‘     â”‚   â”‚
â”‚  â”‚  â”‚ need in heart...    â”‚  â”‚  â•‘ â–¬â–¬â–¬ Oncology (Purple)                             â•‘     â”‚   â”‚
â”‚  â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚  â•‘ â–¬â–¬â–¬ Rare Disease (Blue)                           â•‘     â”‚   â”‚
â”‚  â”‚                          â”‚  â•šâ•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•     â”‚   â”‚
â”‚  â”‚  [+ 3 more areas]        â”‚                                                              â”‚   â”‚
â”‚  â”‚                          â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”   â”‚   â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤  â”‚ ATTRIBUTE DEFINITIONS                                â”‚   â”‚   â”‚
â”‚                              â”‚  â”‚ â€¢ Unmet Need: Medical necessity and treatment gaps  â”‚   â”‚   â”‚
â”‚                              â”‚  â”‚ â€¢ Market Size: Patient population & revenue         â”‚   â”‚   â”‚
â”‚                              â”‚  â”‚ â€¢ Regulatory Support: FDA/EMA pathway favorability  â”‚   â”‚   â”‚
â”‚                              â”‚  â”‚ â€¢ Scientific Validation: Mechanism strength         â”‚   â”‚   â”‚
â”‚                              â”‚  â”‚ â€¢ Competitive Intensity: Number of competing programsâ”‚  â”‚   â”‚
â”‚                              â”‚  â”‚ â€¢ Reimbursement Potential: Payer willingness        â”‚   â”‚   â”‚
â”‚                              â”‚  â”‚ â€¢ Patient Advocacy: Community organization          â”‚   â”‚   â”‚
â”‚                              â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜   â”‚   â”‚
â”‚                              â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜   â”‚
â”‚                                                                                                  â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚
â”‚  â”‚  KEY INSIGHTS                                                                             â”‚  â”‚
â”‚  â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚  â”‚
â”‚  â”‚  â”‚ ğŸ§¬ Rare Disease Dynamics â”‚ â¤ï¸ Cardiology at Scale  â”‚ ğŸ”¬ Innovation Frontiers     â”‚  â”‚  â”‚
â”‚  â”‚  â”‚ â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€ â”‚ â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€  â”‚ â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€ â”‚  â”‚  â”‚
â”‚  â”‚  â”‚ DMD and other rare      â”‚ Cardiovascular area leads â”‚ Gene therapy (DMD), RNAi    â”‚  â”‚  â”‚
â”‚  â”‚  â”‚ diseases show high      â”‚ in market size (9.5) and  â”‚ therapeutics (Cardiology),  â”‚  â”‚  â”‚
â”‚  â”‚  â”‚ unmet need (9.5+) and   â”‚ scientific validation     â”‚ and myosin inhibition       â”‚  â”‚  â”‚
â”‚  â”‚  â”‚ strong patient          â”‚ (9.0), but faces intense  â”‚ represent mechanistic       â”‚  â”‚  â”‚
â”‚  â”‚  â”‚ advocacy, offset by     â”‚ competition (9.0) and     â”‚ differentiation             â”‚  â”‚  â”‚
â”‚  â”‚  â”‚ smaller market size     â”‚ complex reimbursement     â”‚ opportunities with high     â”‚  â”‚  â”‚
â”‚  â”‚  â”‚ (6.5-7.8) but high      â”‚ landscapes.               â”‚ scientific validation.      â”‚  â”‚  â”‚
â”‚  â”‚  â”‚ pricing power via       â”‚                          â”‚                             â”‚  â”‚  â”‚
â”‚  â”‚  â”‚ orphan drug status.     â”‚                          â”‚                             â”‚  â”‚  â”‚
â”‚  â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚  â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚
â”‚                                                                                                  â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

## Mobile Layout (375x667 - iPhone)

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  ğŸ”· [THERAPEUTIC AREA          â”‚
â”‚     INTELLIGENCE]              â”‚
â”‚  Spider Web Analysis           â”‚
â”‚                                â”‚
â”‚  [â†» REFRESH DATA]              â”‚
â”‚  â± Last Updated: 14:32:15     â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  THERAPEUTIC AREAS  5 AREAS   â”‚
â”‚                                â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚
â”‚  â”‚ Duchenne MD             â”‚  â”‚
â”‚  â”‚ Ultra-rare X-linked...  â”‚  â”‚
â”‚  â”‚ PREVALENCE: 1 in 3,500  â”‚  â”‚
â”‚  â”‚ PEAK SALES: 5-8B        â”‚  â”‚
â”‚  â”‚ COMPANIES: SRPT, BMRN   â”‚  â”‚
â”‚  â”‚ [Exon skipping]         â”‚  â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚
â”‚                                â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚
â”‚  â”‚ Cardiovascular          â”‚  â”‚
â”‚  â”‚ Large market with...    â”‚  â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚
â”‚                                â”‚
â”‚  [+ 3 more areas]              â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  SPIDER WEB ANALYSIS           â”‚
â”‚  Science Attributes (0-10)     â”‚
â”‚                                â”‚
â”‚         Unmet Need             â”‚
â”‚            â—¢                   â”‚
â”‚       â•±â”€â”€â”€â”€â”¼â”€â”€â”€â”€â•²              â”‚
â”‚     â•±â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â•²            â”‚
â”‚   â•±â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â•²          â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€           â”‚
â”‚   â•²â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â•±          â”‚
â”‚     â•²â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â•±            â”‚
â”‚       â•²â”€â”€â”€â”€â”¼â”€â”€â”€â”€â•±              â”‚
â”‚      Reimbursement             â”‚
â”‚                                â”‚
â”‚  [Legend with color dots]      â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  KEY INSIGHTS                  â”‚
â”‚                                â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”‚
â”‚  â”‚ ğŸ§¬ Rare Disease           â”‚ â”‚
â”‚  â”‚ Dynamics                  â”‚ â”‚
â”‚  â”‚ DMD and other rare...     â”‚ â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â”‚
â”‚                                â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”‚
â”‚  â”‚ â¤ï¸ Cardiology at Scale   â”‚ â”‚
â”‚  â”‚ Cardiovascular area...    â”‚ â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â”‚
â”‚                                â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”‚
â”‚  â”‚ ğŸ”¬ Innovation Frontiers   â”‚ â”‚
â”‚  â”‚ Gene therapy, RNAi...     â”‚ â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

## Color Palette

### Area Colors (from backend API)
```
DMD:           #00d4ff  â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ (Electric Cyan)
Cardiology:    #fbbf24  â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ (Amber Gold)
IBD:           #10b981  â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ (Emerald Green)
Oncology:      #a855f7  â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ (Aurora Purple)
Rare Disease:  #3b82f6  â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ (Royal Blue)
```

### Theme Colors (Aurora Glass)
```
Background:    #0b0f15  â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ (Deep Space Black)
Panel Glass:   rgba(15, 20, 32, 0.5) + blur(16px)
Border:        rgba(125, 249, 255, 0.12)  (Translucent Cyan)
Text Primary:  #E6F1FF  â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ (Ice White)
Text Secondary:#94a3b8  â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ (Slate)
Accent:        #00d4ff  â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ (Cyan - matches DMD)
```

### Aurora Gradient Overlay
```css
radial-gradient(
  1200px 600px at 10% -10%, 
  rgba(125, 249, 255, 0.15),  /* Cyan glow */
  transparent 50%
)
+
radial-gradient(
  900px 500px at 90% 0%, 
  rgba(192, 132, 252, 0.12),  /* Purple glow */
  transparent 50%
)
```

## Interactive States

### Area Card States

**Default (Inactive)**
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ Duchenne Muscular       â”‚ â† Border: rgba(148, 163, 184, 0.15)
â”‚ Dystrophy               â”‚   Background: rgba(11, 15, 21, 0.6)
â”‚ Description...          â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

**Hover**
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â† Transform: translateX(4px)
â”‚ Duchenne Muscular       â”‚   Border: rgba(125, 249, 255, 0.3)
â”‚ Dystrophy               â”‚   Glow: box-shadow cyan
â”‚ Description...          â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
     â—€â”€â”€ 4px shift
```

**Active (Selected)**
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ Duchenne Muscular       â”‚ â† Border: rgba(125, 249, 255, 0.5)
â”‚ Dystrophy               â”‚   Background: rgba(125, 249, 255, 0.05)
â”‚ Description...          â”‚   Strong glow
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### Chart Interactions

**Hover on Data Point**
```
     Unmet Need
         â—¢
    â•±â”€â”€â”€â”€â—â”€â”€â”€â”€â•²     â† Point enlarges + glow
  â•±â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â•²     Tooltip appears:
â•±â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â•²   â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
                      â”‚ DMD               â”‚
Polygon glows         â”‚ Unmet Need: 9.5   â”‚
Stroke width: 3px     â”‚ (Extremely High)  â”‚
                      â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

**Legend Toggle**
```
LEGEND
â–¬â–¬â–¬ DMD (active)      â† Click to toggle
â–¬â–¬  Cardiology (off)  â† Grayed out, polygon hidden
â–¬â–¬â–¬ IBD (active)
```

## Typography

### Font Stack
```css
--font-mono: 'JetBrains Mono', 'Fira Code', 'SF Mono', 'Consolas', monospace;
--font-sans: system-ui, -apple-system, 'Segoe UI', sans-serif;
```

### Font Sizes & Weights
```
Page Title:        32px, 700, uppercase, letter-spacing: 0.05em
Panel Titles:      16px, 700, uppercase, letter-spacing: 0.05em
Area Names:        14px, 600, uppercase, letter-spacing: 0.03em
Body Text:         12px, 400, line-height: 1.5
Metrics:           12px, 600 (values), 10px (labels)
Attributes:        11px, monospace (on chart)
```

## Glassmorphism Effects

### Panel Glass
```css
background: rgba(15, 20, 32, 0.5);
backdrop-filter: blur(16px);
border: 1px solid rgba(125, 249, 255, 0.12);
box-shadow: 
  0 8px 32px rgba(0, 0, 0, 0.2),
  inset 0 1px 0 rgba(255, 255, 255, 0.03);
```

### Hover Glow
```css
.areaCard:hover {
  box-shadow: -4px 0 16px rgba(125, 249, 255, 0.15);
  border-color: rgba(125, 249, 255, 0.3);
}
```

### Active State
```css
.areaCardActive {
  background: rgba(125, 249, 255, 0.05);
  border-color: rgba(125, 249, 255, 0.5);
  box-shadow: -4px 0 16px rgba(125, 249, 255, 0.2);
}
```

## Spacing System

```
Grid Gap:        2rem (32px)
Panel Padding:   1.5rem (24px)
Card Gap:        1rem (16px)
Card Padding:    1.25rem (20px)
Metric Gap:      0.75rem (12px)
Tag Gap:         0.5rem (8px)
```

## Responsive Breakpoints

```
Desktop:   1200px+   2-column grid
Tablet:    768-1200  Stacked panels
Mobile:    <768px    Single column
```

### Chart Sizing
```
Desktop:   600px Ã— 600px
Tablet:    500px Ã— 500px
Mobile:    400px Ã— 400px (with min-height)
```

## Animation Timings

```
Aurora Pulse:       20s infinite ease-in-out
Chart Animation:    1.2s ease-out cubic
Hover Transitions:  0.3s ease
Card Shift:         0.3s ease (transform)
Glow Fade:          0.3s ease
```

## Loading States

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  SPIDER WEB ANALYSIS        â”‚
â”‚                             â”‚
â”‚         â—¯                   â”‚  â† Spinning loader
â”‚                             â”‚    Border animation
â”‚    Loading therapeutic      â”‚
â”‚    area data...             â”‚
â”‚                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

## Error States

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ âš  Failed to fetch therapeutic areas â”‚
â”‚                                     â”‚
â”‚ Service busy; showing cached data.  â”‚
â”‚                           [Retry]   â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

## Accessibility Features

- **WCAG AAA Contrast**: 7:1+ on all text
- **Keyboard Navigation**: Tab through cards, Enter to toggle
- **Screen Readers**: ARIA labels on all interactive elements
- **Focus Indicators**: Visible cyan outline on focus
- **Touch Targets**: 44px+ minimum for mobile

## Performance Metrics

```
First Contentful Paint:  <1.5s
Time to Interactive:     <3.0s
Chart FPS:               60fps (smooth canvas animation)
Memory Footprint:        <50MB
Bundle Size:             ~150KB (gzipped)
```

---

**Built with**: React 19 + TypeScript + Canvas API  
**Theme**: Aurora Glass Design System  
**Responsive**: Mobile-first with 3 breakpoints  
**Accessible**: WCAG AAA compliant
